RNA干渉（RNAi）ドラッグデリバリーの世界市場レポート2020

• 英文タイトル：Global RNA Interference (RNAi) Drug Delivery Sales Market Report 2020

• レポートコード：MRC2102QY12447 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYリサーチ社の本調査レポートでは、世界のRNA干渉（RNAi）ドラッグデリバリー市場について種類別（ナノ粒子ドラッグデリバリー技術、肺ドラッグデリバリー技術、核酸ドラッグデリバリー技術、アプタマードラッグデリバリー技術）、用途別（感染症、心臓病学、腫瘍学、神経学、眼科、代謝障害）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・RNA干渉（RNAi）ドラッグデリバリー市場の概要 ・世界の主要地域別RNA干渉（RNAi）ドラッグデリバリー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のRNA干渉（RNAi）ドラッグデリバリー市場規模2015-2026：種類別（ナノ粒子ドラッグデリバリー技術、肺ドラッグデリバリー技術、核酸ドラッグデリバリー技術、アプタマードラッグデリバリー技術） ・世界のRNA干渉（RNAi）ドラッグデリバリー市場規模2015-2026：用途別（感染症、心臓病学、腫瘍学、神経学、眼科、代謝障害） ・RNA干渉（RNAi）ドラッグデリバリーの米国市場規模2015-2020 ・RNA干渉（RNAi）ドラッグデリバリーのヨーロッパ市場規模2015-2020 ・RNA干渉（RNAi）ドラッグデリバリーの中国市場規模2015-2020 ・RNA干渉（RNAi）ドラッグデリバリーの日本市場規模2015-2020 ・RNA干渉（RNAi）ドラッグデリバリーの東南アジア市場規模2015-2020 ・RNA干渉（RNAi）ドラッグデリバリーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・RNA干渉（RNAi）ドラッグデリバリーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・RNA干渉（RNAi）ドラッグデリバリーの市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global RNA Interference (RNAi) Drug Delivery Market
The global RNA Interference (RNAi) Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global RNA Interference (RNAi) Drug Delivery Scope and Market Size
The global RNA Interference (RNAi) Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA Interference (RNAi) Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the RNA Interference (RNAi) Drug Delivery market is segmented into
Nanoparticle Drug Delivery Technology
Pulmonary Drug Delivery Technology
Nucleic Acid Drug Delivery Technology
Aptamer Drug Delivery Technology

Segment by Application, the RNA Interference (RNAi) Drug Delivery market is segmented into
Infectious Diseases
Cardiology
Oncology
Neurology
Ophthalmology
Metabolic Disorders

The RNA Interference (RNAi) Drug Delivery market is analysed and market size information is provided by regions (countries). Segment by Application, the RNA Interference (RNAi) Drug Delivery market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and RNA Interference (RNAi) Drug Delivery Market Share Analysis
RNA Interference (RNAi) Drug Delivery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in RNA Interference (RNAi) Drug Delivery business, the date to enter into the RNA Interference (RNAi) Drug Delivery market, RNA Interference (RNAi) Drug Delivery product introduction, recent developments, etc.

The major vendors covered:
Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck & Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc

レポート目次

---

1 RNA Interference (RNAi) Drug Delivery Market Overview
1.1 RNA Interference (RNAi) Drug Delivery Product Scope
1.2 RNA Interference (RNAi) Drug Delivery Segment by Type
1.2.1 Global RNA Interference (RNAi) Drug Delivery Sales by Type (2020-2026)
1.2.2 Nanoparticle Drug Delivery Technology
1.2.3 Pulmonary Drug Delivery Technology
1.2.4 Nucleic Acid Drug Delivery Technology
1.2.5 Aptamer Drug Delivery Technology
1.3 RNA Interference (RNAi) Drug Delivery Segment by Application
1.3.1 Global RNA Interference (RNAi) Drug Delivery Sales Comparison by Application (2020-2026)
1.3.2 Infectious Diseases
1.3.3 Cardiology
1.3.4 Oncology
1.3.5 Neurology
1.3.6 Ophthalmology
1.3.7 Metabolic Disorders
1.4 RNA Interference (RNAi) Drug Delivery Market Estimates and Forecasts (2015-2026)
1.4.1 Global RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2015-2026)
1.4.2 Global RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2015-2026)
1.4.3 Global RNA Interference (RNAi) Drug Delivery Price Trends (2015-2026)

2 RNA Interference (RNAi) Drug Delivery Estimate and Forecast by Region
2.1 Global RNA Interference (RNAi) Drug Delivery Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global RNA Interference (RNAi) Drug Delivery Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Region (2015-2020)
2.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2015-2020)
2.3 Global RNA Interference (RNAi) Drug Delivery Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global RNA Interference (RNAi) Drug Delivery Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States RNA Interference (RNAi) Drug Delivery Estimates and Projections (2015-2026)
2.4.2 Europe RNA Interference (RNAi) Drug Delivery Estimates and Projections (2015-2026)
2.4.3 China RNA Interference (RNAi) Drug Delivery Estimates and Projections (2015-2026)
2.4.4 Japan RNA Interference (RNAi) Drug Delivery Estimates and Projections (2015-2026)
2.4.5 Southeast Asia RNA Interference (RNAi) Drug Delivery Estimates and Projections (2015-2026)
2.4.6 India RNA Interference (RNAi) Drug Delivery Estimates and Projections (2015-2026)
3 Global RNA Interference (RNAi) Drug Delivery Competition Landscape by Players
3.1 Global Top RNA Interference (RNAi) Drug Delivery Players by Sales (2015-2020)
3.2 Global Top RNA Interference (RNAi) Drug Delivery Players by Revenue (2015-2020)
3.3 Global RNA Interference (RNAi) Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Interference (RNAi) Drug Delivery as of 2019)
3.4 Global RNA Interference (RNAi) Drug Delivery Average Price by Company (2015-2020)
3.5 Manufacturers RNA Interference (RNAi) Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key RNA Interference (RNAi) Drug Delivery Players (Opinion Leaders)
4 Global RNA Interference (RNAi) Drug Delivery Market Size by Type
4.1 Global RNA Interference (RNAi) Drug Delivery Historic Market Review by Type (2015-2020)
4.1.1 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
4.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type (2015-2020)
4.1.3 Global RNA Interference (RNAi) Drug Delivery Price by Type (2015-2020)
4.2 Global RNA Interference (RNAi) Drug Delivery Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Global RNA Interference (RNAi) Drug Delivery Price Forecast by Type (2021-2026)
5 Global RNA Interference (RNAi) Drug Delivery Market Size by Application
5.1 Global RNA Interference (RNAi) Drug Delivery Historic Market Review by Application (2015-2020)
5.1.1 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
5.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Application (2015-2020)
5.1.3 Global RNA Interference (RNAi) Drug Delivery Price by Application (2015-2020)
5.2 Global RNA Interference (RNAi) Drug Delivery Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global RNA Interference (RNAi) Drug Delivery Price Forecast by Application (2021-2026)

6 United States RNA Interference (RNAi) Drug Delivery Market Facts & Figures
6.1 United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
6.2 United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
6.3 United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)

7 Europe RNA Interference (RNAi) Drug Delivery Market Facts & Figures
7.1 Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
7.2 Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
7.3 Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)

8 China RNA Interference (RNAi) Drug Delivery Market Facts & Figures
8.1 China RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
8.2 China RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
8.3 China RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)

9 Japan RNA Interference (RNAi) Drug Delivery Market Facts & Figures
9.1 Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (3015-3030)
9.2 Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
9.3 Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)

10 Southeast Asia RNA Interference (RNAi) Drug Delivery Market Facts & Figures
10.1 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
10.2 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
10.3 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)

11 India RNA Interference (RNAi) Drug Delivery Market Facts & Figures
11.1 India RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
11.2 India RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
11.3 India RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in RNA Interference (RNAi) Drug Delivery Business
12.1 Metabolic disorders
12.1.1 Metabolic disorders Corporation Information
12.1.2 Metabolic disorders Business Overview
12.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Metabolic disorders RNA Interference (RNAi) Drug Delivery Products Offered
12.1.5 Metabolic disorders Recent Development
12.2 Alnylam Pharmaceuticals Inc
12.2.1 Alnylam Pharmaceuticals Inc Corporation Information
12.2.2 Alnylam Pharmaceuticals Inc Business Overview
12.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.2.5 Alnylam Pharmaceuticals Inc Recent Development
12.3 Merck & Co. Inc
12.3.1 Merck & Co. Inc Corporation Information
12.3.2 Merck & Co. Inc Business Overview
12.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.3.5 Merck & Co. Inc Recent Development
12.4 Access Pharmaceuticals Inc
12.4.1 Access Pharmaceuticals Inc Corporation Information
12.4.2 Access Pharmaceuticals Inc Business Overview
12.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.4.5 Access Pharmaceuticals Inc Recent Development
12.5 Dicerna Pharmaceuticals Inc
12.5.1 Dicerna Pharmaceuticals Inc Corporation Information
12.5.2 Dicerna Pharmaceuticals Inc Business Overview
12.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.5.5 Dicerna Pharmaceuticals Inc Recent Development
12.6 Calondo Pharmaceuticals Inc
12.6.1 Calondo Pharmaceuticals Inc Corporation Information
12.6.2 Calondo Pharmaceuticals Inc Business Overview
12.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.6.5 Calondo Pharmaceuticals Inc Recent Development
12.7 Marina Biotech Inc
12.7.1 Marina Biotech Inc Corporation Information
12.7.2 Marina Biotech Inc Business Overview
12.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.7.5 Marina Biotech Inc Recent Development
12.8 RXi Pharmaceuticals Corp
12.8.1 RXi Pharmaceuticals Corp Corporation Information
12.8.2 RXi Pharmaceuticals Corp Business Overview
12.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.8.4 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Products Offered
12.8.5 RXi Pharmaceuticals Corp Recent Development
12.9 Quark Pharmaceuticals Inc
12.9.1 Quark Pharmaceuticals Inc Corporation Information
12.9.2 Quark Pharmaceuticals Inc Business Overview
12.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.9.5 Quark Pharmaceuticals Inc Recent Development
12.10 Silence Therapeutics plc
12.10.1 Silence Therapeutics plc Corporation Information
12.10.2 Silence Therapeutics plc Business Overview
12.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Products Offered
12.10.5 Silence Therapeutics plc Recent Development
12.11 Tacere Therapeutics Inc
12.11.1 Tacere Therapeutics Inc Corporation Information
12.11.2 Tacere Therapeutics Inc Business Overview
12.11.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.11.5 Tacere Therapeutics Inc Recent Development
12.12 PhaseRx Inc
12.12.1 PhaseRx Inc Corporation Information
12.12.2 PhaseRx Inc Business Overview
12.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.12.4 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.12.5 PhaseRx Inc Recent Development
12.13 Sirnaomics Inc
12.13.1 Sirnaomics Inc Corporation Information
12.13.2 Sirnaomics Inc Business Overview
12.13.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.13.5 Sirnaomics Inc Recent Development
12.14 Traversa Therapeutics Inc
12.14.1 Traversa Therapeutics Inc Corporation Information
12.14.2 Traversa Therapeutics Inc Business Overview
12.14.3 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Products Offered
12.14.5 Traversa Therapeutics Inc Recent Development

13 RNA Interference (RNAi) Drug Delivery Manufacturing Cost Analysis
13.1 RNA Interference (RNAi) Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
13.4 RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 RNA Interference (RNAi) Drug Delivery Distributors List
14.3 RNA Interference (RNAi) Drug Delivery Customers

15 Market Dynamics
15.1 RNA Interference (RNAi) Drug Delivery Market Trends
15.2 RNA Interference (RNAi) Drug Delivery Opportunities and Drivers
15.3 RNA Interference (RNAi) Drug Delivery Market Challenges
15.4 RNA Interference (RNAi) Drug Delivery Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market RNA Interference (RNAi) Drug Delivery Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) by Region (2015-2020)
Table 5. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Region (2015-2020)
Table 6. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Region (2015-2020)
Table 8. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global RNA Interference (RNAi) Drug Delivery Sales Market Share Forecast by Region (2021-2026)
Table 10. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global RNA Interference (RNAi) Drug Delivery Revenue Share Forecast by Region (2021-2026)
Table 12. Global RNA Interference (RNAi) Drug Delivery (K Units) of Key Companies (2015-2020)
Table 13. Global RNA Interference (RNAi) Drug Delivery Sales Share by Company (2015-2020)
Table 14. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) by Company (2015-2020)
Table 15. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Company (2015-2020)
Table 16. Global RNA Interference (RNAi) Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Interference (RNAi) Drug Delivery as of 2019)
Table 17. Global RNA Interference (RNAi) Drug Delivery Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers RNA Interference (RNAi) Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key RNA Interference (RNAi) Drug Delivery Players
Table 22. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 23. Global RNA Interference (RNAi) Drug Delivery Sales Share by Type (2015-2020)
Table 24. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global RNA Interference (RNAi) Drug Delivery Price (K Units) by Type (2015-2020)
Table 26. Global RNA Interference (RNAi) Drug Delivery Sales Share by Type (2021-2026)
Table 27. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2021-2026)
Table 29. Global RNA Interference (RNAi) Drug Delivery Price (K Units) by Type (2021-2026)
Table 30. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 31. Global RNA Interference (RNAi) Drug Delivery Sales Share by Application (2015-2020)
Table 32. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global RNA Interference (RNAi) Drug Delivery Price (K Units) by Application (2015-2020)
Table 34. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2021-2026)
Table 35. Global RNA Interference (RNAi) Drug Delivery Sales Share by Application (2021-2026)
Table 36. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Application (2021-2026)
Table 38. Global RNA Interference (RNAi) Drug Delivery Price (K Units) by Application (2021-2026)
Table 39. United States RNA Interference (RNAi) Drug Delivery Sales (K Units) by Company (2015-2020)
Table 40. United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
Table 41. United States RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 42. United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 43. United States RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 44. United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
Table 45. Europe RNA Interference (RNAi) Drug Delivery Sales (K Units) by Company (2015-2020)
Table 46. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
Table 47. Europe RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 48. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 49. Europe RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 50. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 51. China RNA Interference (RNAi) Drug Delivery Sales (K Units) by Company (2015-2020)
Table 52. China RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
Table 53. China RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 54. China RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 55. China RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 56. China RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
Table 57. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Company (2015-2020)
Table 58. Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
Table 59. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 60. Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 61. Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 62. Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
Table 69. India RNA Interference (RNAi) Drug Delivery Sales (K Units) by Company (2015-2020)
Table 70. India RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2015-2020)
Table 71. India RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2015-2020)
Table 72. India RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2015-2020)
Table 73. India RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2015-2020)
Table 74. India RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2015-2020)
Table 75. Metabolic disorders Corporation Information
Table 76. Metabolic disorders Description and Business Overview
Table 77. Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Metabolic disorders RNA Interference (RNAi) Drug Delivery Product
Table 79. Metabolic disorders Recent Development
Table 80. Alnylam Pharmaceuticals Inc Corporation Information
Table 81. Alnylam Pharmaceuticals Inc Description and Business Overview
Table 82. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product
Table 84. Alnylam Pharmaceuticals Inc Recent Development
Table 85. Merck & Co. Inc Corporation Information
Table 86. Merck & Co. Inc Description and Business Overview
Table 87. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product
Table 89. Merck & Co. Inc Recent Development
Table 90. Access Pharmaceuticals Inc Corporation Information
Table 91. Access Pharmaceuticals Inc Description and Business Overview
Table 92. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product
Table 94. Access Pharmaceuticals Inc Recent Development
Table 95. Dicerna Pharmaceuticals Inc Corporation Information
Table 96. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 97. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product
Table 99. Dicerna Pharmaceuticals Inc Recent Development
Table 100. Calondo Pharmaceuticals Inc Corporation Information
Table 101. Calondo Pharmaceuticals Inc Description and Business Overview
Table 102. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product
Table 104. Calondo Pharmaceuticals Inc Recent Development
Table 105. Marina Biotech Inc Corporation Information
Table 106. Marina Biotech Inc Description and Business Overview
Table 107. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product
Table 109. Marina Biotech Inc Recent Development
Table 110. RXi Pharmaceuticals Corp Corporation Information
Table 111. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. RXi Pharmaceuticals Corp Description and Business Overview
Table 113. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product
Table 114. RXi Pharmaceuticals Corp Recent Development
Table 115. Quark Pharmaceuticals Inc Corporation Information
Table 116. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Quark Pharmaceuticals Inc Description and Business Overview
Table 118. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product
Table 119. Quark Pharmaceuticals Inc Recent Development
Table 120. Silence Therapeutics plc Corporation Information
Table 121. Silence Therapeutics plc Description and Business Overview
Table 122. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product
Table 124. Silence Therapeutics plc Recent Development
Table 125. Tacere Therapeutics Inc Corporation Information
Table 126. Tacere Therapeutics Inc Description and Business Overview
Table 127. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product
Table 129. Tacere Therapeutics Inc Recent Development
Table 130. PhaseRx Inc Corporation Information
Table 131. PhaseRx Inc Description and Business Overview
Table 132. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product
Table 134. PhaseRx Inc Recent Development
Table 135. Sirnaomics Inc Corporation Information
Table 136. Sirnaomics Inc Description and Business Overview
Table 137. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product
Table 139. Sirnaomics Inc Recent Development
Table 140. Traversa Therapeutics Inc Corporation Information
Table 141. Traversa Therapeutics Inc Description and Business Overview
Table 142. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product
Table 144. Traversa Therapeutics Inc Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. RNA Interference (RNAi) Drug Delivery Distributors List
Table 148. RNA Interference (RNAi) Drug Delivery Customers List
Table 149. RNA Interference (RNAi) Drug Delivery Market Key Trends
Table 150. RNA Interference (RNAi) Drug Delivery Key Opportunities and Drivers
Table 151. RNA Interference (RNAi) Drug Delivery Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Interference (RNAi) Drug Delivery Product Picture
Figure 2. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global RNA Interference (RNAi) Drug Delivery Market Share by Application in 2020 & 2026
Figure 6. Infectious Diseases Examples
Figure 7. Cardiology Examples
Figure 8. Oncology Examples
Figure 9. Neurology Examples
Figure 10. Ophthalmology Examples
Figure 11. Metabolic Disorders Examples
Figure 12. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Growth Rate (2015-2026)
Figure 13. Global RNA Interference (RNAi) Drug Delivery Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global RNA Interference (RNAi) Drug Delivery Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 15. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States RNA Interference (RNAi) Drug Delivery Sales (K Units) Growth Rate (2015-2026)
Figure 19. Europe RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe RNA Interference (RNAi) Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China RNA Interference (RNAi) Drug Delivery Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan RNA Interference (RNAi) Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India RNA Interference (RNAi) Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest RNA Interference (RNAi) Drug Delivery Players Market Share by Revenue in RNA Interference (RNAi) Drug Delivery 2015 & 2019
Figure 30. RNA Interference (RNAi) Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2015-2020)
Figure 32. Global RNA Interference (RNAi) Drug Delivery Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Application (2015-2020)
Figure 34. Global RNA Interference (RNAi) Drug Delivery Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 36. United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 37. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Company in 2019
Figure 38. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 39. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2019
Figure 40. China RNA Interference (RNAi) Drug Delivery Sales Market Share by Company in 2019
Figure 41. China RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 42. China RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2019
Figure 43. Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Company in 2019
Figure 44. Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 45. Japan RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2019
Figure 46. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Company in 2019
Figure 47. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 48. Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2019
Figure 49. India RNA Interference (RNAi) Drug Delivery Sales Market Share by Company in 2019
Figure 50. India RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2019
Figure 51. India RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2019
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of RNA Interference (RNAi) Drug Delivery
Figure 54. Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
Figure 55. RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

---